| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRB1 GABRB3 GABRR1 OR2T29 OR10A7 OR8U1 GALR1 CHRNA9 OR1B1 MCHR2 P2RY8 OR2T5 OR2T4 GRM8 ADGRG4 OR8U8 OPRM1 LPAR6 OR52N2 OR4C13 TACR2 TAS2R45 LTB4R IL2RA MUSK | 7.78e-08 | 1353 | 111 | 25 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GABRB1 OR2T29 OR10A7 OR8U1 GALR1 OR1B1 MCHR2 P2RY8 OR2T5 OR2T4 GRM8 ADGRG4 OR8U8 OPRM1 LPAR6 OR52N2 OR4C13 TACR2 TAS2R45 LTB4R | 7.97e-08 | 884 | 111 | 20 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB1 GABRB3 GPR89B GABRR1 CHRNA9 SLC38A4 SLC22A24 SLC9C2 MFSD12 OPRM1 SLC5A11 SLC7A8 SLC9C1 CACNA2D4 SLC9A3 CLCN7 CLCA2 SLC10A5 SCN3A SLC35F6 GPR89A SLC37A4 SLC9A6 | 1.11e-07 | 1180 | 111 | 23 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB1 GABRB3 GPR89B GABRR1 CHRNA9 SLC38A4 SLC9C2 OPRM1 SLC5A11 SLC9C1 CACNA2D4 SLC9A3 CLCN7 CLCA2 SLC10A5 SCN3A GPR89A SLC9A6 | 3.69e-07 | 793 | 111 | 18 | GO:0015075 |
| GeneOntologyMolecularFunction | transporter activity | GABRB1 GABRB3 GPR89B GABRR1 CHRNA9 SLC38A4 SLC22A24 SLC9C2 MFSD12 OPRM1 SLC5A11 SLC7A8 SLC9C1 CACNA2D4 SLC9A3 CLCN7 CLCA2 SLC10A5 SCN3A SLC35F6 GPR89A SLC37A4 SLC9A6 | 5.29e-07 | 1289 | 111 | 23 | GO:0005215 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC38A4 SLC9C2 MFSD12 SLC5A11 SLC7A8 SLC9C1 SLC9A3 CLCN7 SLC10A5 SLC37A4 SLC9A6 | 8.02e-07 | 296 | 111 | 11 | GO:0015291 |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 8.67e-07 | 14 | 111 | 4 | GO:0015386 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB1 GABRB3 GABRR1 CHRNA9 SLC38A4 SLC9C2 OPRM1 SLC5A11 SLC9C1 CACNA2D4 SLC9A3 CLCN7 CLCA2 SLC10A5 SCN3A SLC37A4 SLC9A6 | 9.54e-07 | 758 | 111 | 17 | GO:0015318 |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 1.56e-06 | 16 | 111 | 4 | GO:0015385 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.73e-06 | 103 | 111 | 7 | GO:0005253 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 3.29e-06 | 19 | 111 | 4 | GO:0022821 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.12e-06 | 171 | 111 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRB1 GABRB3 GPR89B GABRR1 CHRNA9 OPRM1 SLC9C1 CACNA2D4 CLCN7 CLCA2 SCN3A GPR89A | 9.50e-06 | 459 | 111 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | antiporter activity | 1.21e-05 | 138 | 111 | 7 | GO:0015297 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 1.44e-05 | 27 | 111 | 4 | GO:0051139 | |
| GeneOntologyMolecularFunction | gated channel activity | GABRB1 GABRB3 GPR89B GABRR1 CHRNA9 OPRM1 CACNA2D4 CLCN7 CLCA2 GPR89A | 1.73e-05 | 334 | 111 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.17e-05 | 151 | 111 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | channel activity | GABRB1 GABRB3 GPR89B GABRR1 CHRNA9 OPRM1 SLC9C1 CACNA2D4 CLCN7 CLCA2 SCN3A GPR89A | 3.58e-05 | 525 | 111 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB1 GABRB3 GPR89B GABRR1 CHRNA9 OPRM1 SLC9C1 CACNA2D4 CLCN7 CLCA2 SCN3A GPR89A | 3.64e-05 | 526 | 111 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CHRNA9 SLC38A4 SLC9C2 OPRM1 SLC5A11 SLC9C1 CACNA2D4 SLC9A3 SLC10A5 SCN3A SLC9A6 | 5.66e-05 | 465 | 111 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC38A4 SLC9C2 MFSD12 SLC5A11 SLC7A8 SLC9C1 SLC9A3 CLCN7 SLC10A5 SLC37A4 SLC9A6 | 7.11e-05 | 477 | 111 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 9.44e-05 | 43 | 111 | 4 | GO:0140828 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 1.07e-04 | 17 | 111 | 3 | GO:0008308 | |
| GeneOntologyMolecularFunction | chloride channel activity | 1.18e-04 | 86 | 111 | 5 | GO:0005254 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 1.28e-04 | 18 | 111 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 1.52e-04 | 19 | 111 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.71e-04 | 50 | 111 | 4 | GO:0099095 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 2.38e-04 | 22 | 111 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 3.89e-04 | 171 | 111 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 4.72e-04 | 65 | 111 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 4.72e-04 | 65 | 111 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 6.70e-04 | 125 | 111 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 6.78e-04 | 431 | 111 | 9 | GO:0004984 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CHRNA9 SLC38A4 SLC9C2 OPRM1 SLC5A11 SLC9C1 CACNA2D4 SLC9A3 SLC10A5 SCN3A SLC9A6 | 7.40e-04 | 627 | 111 | 11 | GO:0022890 |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 8.86e-04 | 133 | 111 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 8.96e-04 | 77 | 111 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.11e-03 | 140 | 111 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CHRNA9 SLC38A4 SLC9C2 OPRM1 SLC5A11 SLC9C1 CACNA2D4 SLC9A3 SLC10A5 SCN3A SLC9A6 | 1.18e-03 | 664 | 111 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | MAP kinase tyrosine phosphatase activity | 1.34e-03 | 10 | 111 | 2 | GO:0033550 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.47e-03 | 301 | 111 | 7 | GO:0022853 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 1.53e-03 | 41 | 111 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | protein tyrosine/threonine phosphatase activity | 1.63e-03 | 11 | 111 | 2 | GO:0008330 | |
| GeneOntologyMolecularFunction | MAP kinase tyrosine/serine/threonine phosphatase activity | 2.29e-03 | 13 | 111 | 2 | GO:0017017 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.35e-03 | 100 | 111 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 3.20e-03 | 53 | 111 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | alanine transmembrane transporter activity | 3.49e-03 | 16 | 111 | 2 | GO:0022858 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.50e-03 | 182 | 111 | 5 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 3.67e-03 | 184 | 111 | 5 | GO:0022832 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 3.93e-03 | 57 | 111 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | protein kinase B binding | 3.94e-03 | 17 | 111 | 2 | GO:0043422 | |
| GeneOntologyMolecularFunction | MAP kinase phosphatase activity | 4.42e-03 | 18 | 111 | 2 | GO:0033549 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.49e-03 | 193 | 111 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 4.54e-03 | 60 | 111 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.90e-03 | 197 | 111 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | GABA receptor binding | 5.45e-03 | 20 | 111 | 2 | GO:0050811 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 7.80e-03 | 24 | 111 | 2 | GO:0099507 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR2T29 OR10A7 OR8U1 CHRNA9 OR1B1 BACE1 OR2T5 OR2T4 GRM8 OR8U8 CACNA2D4 OR52N2 OR4C13 TAS2R45 | 2.37e-06 | 582 | 109 | 14 | GO:0050906 |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 1.06e-05 | 94 | 109 | 6 | GO:0051453 | |
| GeneOntologyBiologicalProcess | sodium ion import across plasma membrane | 1.18e-05 | 27 | 109 | 4 | GO:0098719 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 1.60e-05 | 101 | 109 | 6 | GO:0030641 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.70e-05 | 153 | 109 | 7 | GO:0098656 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR2T29 OR10A7 OR8U1 CHRNA9 OR1B1 BACE1 OR2T5 OR2T4 GRM8 OR8U8 CACNA2D4 OR52N2 OR4C13 TAS2R45 | 2.71e-05 | 722 | 109 | 14 | GO:0051606 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRB1 GABRB3 GPR89B GABRR1 CHRNA9 SLC38A4 SLC22A24 SLC9C2 OPRM1 SLC5A11 SLC9C1 CACNA2D4 SLC9A3 CLCN7 CLCA2 SLC10A5 SCN3A GPR89A TACR2 SLC9A6 | 3.08e-05 | 1374 | 109 | 20 | GO:0006811 |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 3.41e-05 | 35 | 109 | 4 | GO:0007214 | |
| GeneOntologyBiologicalProcess | regulation of pH | 4.25e-05 | 120 | 109 | 6 | GO:0006885 | |
| GeneOntologyBiologicalProcess | sensory perception | OR2T29 OR10A7 OR8U1 CHRNA9 OR1B1 MYO7A BACE1 OR2T5 OR2T4 GRM8 OR8U8 OPRM1 CACNA2D4 OR52N2 HPS1 OR4C13 TAS2R45 | 4.60e-05 | 1072 | 109 | 17 | GO:0007600 |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 5.37e-05 | 183 | 109 | 7 | GO:0006820 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 7.87e-05 | 134 | 109 | 6 | GO:0098661 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.07e-04 | 275 | 109 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR2T29 OR10A7 OR8U1 GALR1 OR1B1 MCHR2 P2RY8 OR2T5 OR2T4 GRM8 ADGRG4 OR8U8 OPRM1 LPAR6 OR52N2 OR4C13 TACR2 TAS2R45 LTB4R | 1.21e-04 | 1395 | 109 | 19 | GO:0007186 |
| GeneOntologyBiologicalProcess | L-alanine import across plasma membrane | 1.65e-04 | 4 | 109 | 2 | GO:1904273 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRB1 GABRB3 GPR89B GABRR1 CHRNA9 SLC38A4 SLC9C2 OPRM1 SLC9C1 CACNA2D4 SLC9A3 CLCN7 CLCA2 SCN3A GPR89A SLC9A6 | 2.48e-04 | 1115 | 109 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | OR2T29 OR10A7 OR8U1 OR1B1 OR2T5 OR2T4 OR8U8 OR52N2 OR4C13 TAS2R45 | 2.51e-04 | 485 | 109 | 10 | GO:0050907 |
| GeneOntologyBiologicalProcess | L-alanine transmembrane transport | 2.74e-04 | 5 | 109 | 2 | GO:1904557 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRB1 GABRB3 GABRR1 CHRNA9 SLC38A4 SLC9C2 OPRM1 SLC9C1 CACNA2D4 SLC9A3 CLCN7 CLCA2 SCN3A SLC37A4 SLC9A6 | 2.94e-04 | 1017 | 109 | 15 | GO:0098660 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 3.22e-04 | 112 | 109 | 5 | GO:1902476 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 3.91e-04 | 180 | 109 | 6 | GO:0015698 | |
| GeneOntologyBiologicalProcess | negative regulation of luteinizing hormone secretion | 4.09e-04 | 6 | 109 | 2 | GO:0033685 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR2T29 OR10A7 OR8U1 OR1B1 OR2T5 OR2T4 OR8U8 OR52N2 OR4C13 TAS2R45 | 4.62e-04 | 524 | 109 | 10 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 4.80e-04 | 432 | 109 | 9 | GO:0050911 | |
| GeneOntologyBiologicalProcess | cellular response to histamine | 5.71e-04 | 7 | 109 | 2 | GO:0071420 | |
| GeneOntologyBiologicalProcess | chloride transport | 5.94e-04 | 128 | 109 | 5 | GO:0006821 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR2T29 OR10A7 OR8U1 OR1B1 OR2T5 OR2T4 OR8U8 OR52N2 OR4C13 TAS2R45 | 6.45e-04 | 547 | 109 | 10 | GO:0007606 |
| GeneOntologyCellularComponent | GABA-A receptor complex | 1.29e-04 | 19 | 110 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRB1 GABRB3 GPR89B GABRR1 CHRNA9 CACNA2D4 CLCN7 SCN3A GPR89A | 1.75e-04 | 378 | 110 | 9 | GO:0034702 |
| GeneOntologyCellularComponent | GABA receptor complex | 1.76e-04 | 21 | 110 | 3 | GO:1902710 | |
| GeneOntologyCellularComponent | chloride channel complex | 2.31e-04 | 57 | 110 | 4 | GO:0034707 | |
| GeneOntologyCellularComponent | transporter complex | GABRB1 GABRB3 GPR89B GABRR1 CHRNA9 ERGIC2 CACNA2D4 CLCN7 SCN3A GPR89A | 6.52e-04 | 550 | 110 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | vacuole | MYO7A ACLY BACE1 RNF13 FYCO1 RB1CC1 MFSD12 TMBIM1 CLCN7 MAP1LC3C HPS1 SLC35F6 NKG7 | 1.02e-03 | 913 | 110 | 13 | GO:0005773 |
| GeneOntologyCellularComponent | lysosome | MYO7A ACLY BACE1 RNF13 FYCO1 RB1CC1 MFSD12 TMBIM1 CLCN7 HPS1 SLC35F6 NKG7 | 1.16e-03 | 811 | 110 | 12 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | MYO7A ACLY BACE1 RNF13 FYCO1 RB1CC1 MFSD12 TMBIM1 CLCN7 HPS1 SLC35F6 NKG7 | 1.16e-03 | 811 | 110 | 12 | GO:0000323 |
| GeneOntologyCellularComponent | vacuolar membrane | MYO7A RNF13 RB1CC1 MFSD12 TMBIM1 CLCN7 MAP1LC3C SLC35F6 NKG7 | 1.44e-03 | 507 | 110 | 9 | GO:0005774 |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.76e-03 | 164 | 110 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRB1 GABRB3 GPR89B GABRR1 CHRNA9 CACNA2D4 CLCN7 SCN3A GPR89A | 1.78e-03 | 523 | 110 | 9 | GO:1902495 |
| Domain | Cation/H_exchanger_CPA1 | 3.38e-07 | 11 | 108 | 4 | IPR018422 | |
| Domain | Na_H_Exchanger | 1.01e-06 | 14 | 108 | 4 | PF00999 | |
| Domain | Cation/H_exchanger | 1.01e-06 | 14 | 108 | 4 | IPR006153 | |
| Domain | GPCR_Rhodpsn_7TM | OR2T29 OR10A7 OR8U1 GALR1 OR1B1 MCHR2 P2RY8 OR2T5 OR2T4 OR8U8 OPRM1 LPAR6 OR52N2 OR4C13 TACR2 LTB4R | 1.49e-06 | 670 | 108 | 16 | IPR017452 |
| Domain | 7tm_1 | OR2T29 OR10A7 OR8U1 GALR1 OR1B1 MCHR2 P2RY8 OR2T5 OR2T4 OR8U8 OPRM1 LPAR6 OR52N2 OR4C13 TACR2 LTB4R | 1.70e-06 | 677 | 108 | 16 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR2T29 OR10A7 OR8U1 GALR1 OR1B1 MCHR2 P2RY8 OR2T5 OR2T4 OR8U8 OPRM1 LPAR6 OR52N2 OR4C13 TACR2 LTB4R | 1.98e-06 | 685 | 108 | 16 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR2T29 OR10A7 OR8U1 GALR1 OR1B1 MCHR2 P2RY8 OR2T5 OR2T4 OR8U8 OPRM1 LPAR6 OR52N2 OR4C13 TACR2 LTB4R | 2.22e-06 | 691 | 108 | 16 | PS50262 |
| Domain | GPCR_Rhodpsn | OR2T29 OR10A7 OR8U1 GALR1 OR1B1 MCHR2 P2RY8 OR2T5 OR2T4 OR8U8 OPRM1 LPAR6 OR52N2 OR4C13 TACR2 LTB4R | 2.26e-06 | 692 | 108 | 16 | IPR000276 |
| Domain | GABAAb_rcpt | 9.90e-05 | 3 | 108 | 2 | IPR002289 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.31e-04 | 45 | 108 | 4 | IPR018000 | |
| Domain | Neur_chan_memb | 1.43e-04 | 46 | 108 | 4 | PF02932 | |
| Domain | Neur_chan_LBD | 1.56e-04 | 47 | 108 | 4 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.56e-04 | 47 | 108 | 4 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 1.56e-04 | 47 | 108 | 4 | IPR006029 | |
| Domain | - | 1.56e-04 | 47 | 108 | 4 | 2.70.170.10 | |
| Domain | Neur_channel | 1.56e-04 | 47 | 108 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.56e-04 | 47 | 108 | 4 | IPR006202 | |
| Domain | GABAA/Glycine_rcpt | 3.06e-04 | 23 | 108 | 3 | IPR006028 | |
| Domain | Olfact_rcpt | 4.61e-04 | 393 | 108 | 9 | IPR000725 | |
| Domain | ENTH | 4.89e-04 | 6 | 108 | 2 | PF01417 | |
| Domain | Bax_inhibitor_1-related | 4.89e-04 | 6 | 108 | 2 | IPR006214 | |
| Domain | ENTH | 1.16e-03 | 9 | 108 | 2 | PS50942 | |
| Domain | NaH_exchanger | 1.16e-03 | 9 | 108 | 2 | IPR004709 | |
| Domain | ENTH | 1.16e-03 | 9 | 108 | 2 | SM00273 | |
| Domain | MKP | 1.45e-03 | 10 | 108 | 2 | IPR008343 | |
| Domain | ENTH | 1.45e-03 | 10 | 108 | 2 | IPR013809 | |
| Domain | EamA_dom | 2.88e-03 | 14 | 108 | 2 | IPR000620 | |
| Domain | EamA | 2.88e-03 | 14 | 108 | 2 | PF00892 | |
| Domain | VWA | 4.17e-03 | 56 | 108 | 3 | PF00092 | |
| Domain | UIM | 4.77e-03 | 18 | 108 | 2 | PF02809 | |
| Domain | BRCT | 5.31e-03 | 19 | 108 | 2 | PF00533 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | GABRB1 GABRB3 GABRR1 GALR1 CHRNA9 MCHR2 P2RY8 GRM8 OPRM1 LPAR6 TACR2 LTB4R | 1.17e-07 | 272 | 88 | 12 | M13380 |
| Pubmed | 7.97e-09 | 81 | 111 | 7 | 22723691 | ||
| Pubmed | 5.12e-06 | 11 | 111 | 3 | 23043107 | ||
| Pubmed | GABAA receptors involved in sleep and anaesthesia: β1- versus β3-containing assemblies. | 1.01e-05 | 2 | 111 | 2 | 21735059 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 26950270 | ||
| Pubmed | Multiple modes for conferring surface expression of homomeric beta1 GABAA receptors. | 1.01e-05 | 2 | 111 | 2 | 18650446 | |
| Pubmed | Functional μ-Opioid-Galanin Receptor Heteromers in the Ventral Tegmental Area. | 1.01e-05 | 2 | 111 | 2 | 28007761 | |
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 29351414 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 22572823 | ||
| Pubmed | 1.01e-05 | 2 | 111 | 2 | 12353027 | ||
| Pubmed | Ptchd1 mediates opioid tolerance via cholesterol-dependent effects on μ-opioid receptor trafficking. | 1.01e-05 | 2 | 111 | 2 | 35982154 | |
| Pubmed | GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus. | 1.01e-05 | 2 | 111 | 2 | 18794847 | |
| Pubmed | 2.49e-05 | 18 | 111 | 3 | 19078961 | ||
| Pubmed | Epsins Negatively Regulate Aortic Endothelial Cell Function by Augmenting Inflammatory Signaling. | 3.02e-05 | 3 | 111 | 2 | 34440686 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 28717225 | ||
| Pubmed | Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development. | 3.02e-05 | 3 | 111 | 2 | 32960814 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 32220963 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 18281286 | ||
| Pubmed | Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling. | 3.02e-05 | 3 | 111 | 2 | 23187125 | |
| Pubmed | [Functional Hypermethylation of ALDH1L1, PLCL2, and PPP2R3A in Colon Cancer]. | 3.02e-05 | 3 | 111 | 2 | 32392189 | |
| Pubmed | GABAA receptor beta 1, beta 2, and beta 3 subunits: comparisons in DBA/2J and C57BL/6J mice. | 3.02e-05 | 3 | 111 | 2 | 7893750 | |
| Pubmed | Expression and distribution of GABAA receptor subtypes in human alcoholic cerebral cortex. | 3.02e-05 | 3 | 111 | 2 | 11085308 | |
| Pubmed | GABAA receptor beta subunit mRNA expression in the human alcoholic brain. | 3.02e-05 | 3 | 111 | 2 | 15337300 | |
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 1282920 | ||
| Pubmed | 3.02e-05 | 3 | 111 | 2 | 27634757 | ||
| Pubmed | 5.43e-05 | 126 | 111 | 5 | 17897319 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 24311377 | ||
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 22981535 | ||
| Pubmed | The epsin family of endocytic adaptors promotes fibrosarcoma migration and invasion. | 6.03e-05 | 4 | 111 | 2 | 20709745 | |
| Pubmed | T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. | 6.03e-05 | 4 | 111 | 2 | 15753207 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 32770009 | ||
| Pubmed | Cerebellar Neurodegeneration and Neuronal Circuit Remodeling in Golgi pH Regulator-Deficient Mice. | 6.03e-05 | 4 | 111 | 2 | 31118204 | |
| Pubmed | 6.03e-05 | 4 | 111 | 2 | 23791643 | ||
| Pubmed | 6.30e-05 | 130 | 111 | 5 | 12421765 | ||
| Pubmed | Odorant and vomeronasal receptor genes in two mouse genome assemblies. | 9.52e-05 | 74 | 111 | 4 | 15081110 | |
| Pubmed | Muscle-like nicotinic receptor accessory molecules in sensory hair cells of the inner ear. | 1.00e-04 | 5 | 111 | 2 | 18420419 | |
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 18195715 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 15198677 | ||
| Pubmed | 1.00e-04 | 5 | 111 | 2 | 12595241 | ||
| Pubmed | Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit. | 1.00e-04 | 5 | 111 | 2 | 9039914 | |
| Pubmed | Intersectin, a novel adaptor protein with two Eps15 homology and five Src homology 3 domains. | 1.00e-04 | 5 | 111 | 2 | 9813051 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 1.14e-04 | 340 | 111 | 7 | 11875048 | |
| Pubmed | 1.14e-04 | 340 | 111 | 7 | 11802173 | ||
| Pubmed | 1.21e-04 | 343 | 111 | 7 | 32295537 | ||
| Pubmed | 1.27e-04 | 346 | 111 | 7 | 14611657 | ||
| Pubmed | 1.33e-04 | 31 | 111 | 3 | 20813000 | ||
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 18440869 | ||
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 11004484 | ||
| Pubmed | Evolution of GABA(A) receptor diversity in the human genome. | 1.50e-04 | 6 | 111 | 2 | 10023064 | |
| Pubmed | The GABAA Receptor β Subunit Is Required for Inhibitory Transmission. | 1.50e-04 | 6 | 111 | 2 | 29706582 | |
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 25122462 | ||
| Pubmed | Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes. | 1.50e-04 | 6 | 111 | 2 | 20560679 | |
| Pubmed | Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes. | 1.50e-04 | 6 | 111 | 2 | 30102256 | |
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 25764978 | ||
| Pubmed | 1.50e-04 | 6 | 111 | 2 | 25871009 | ||
| Pubmed | The ubiquitin-like protein PLIC-2 is a negative regulator of G protein-coupled receptor endocytosis. | 2.10e-04 | 7 | 111 | 2 | 18199683 | |
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 16015370 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 2.10e-04 | 7 | 111 | 2 | 20843900 | |
| Pubmed | 2.10e-04 | 7 | 111 | 2 | 16754670 | ||
| Pubmed | 2.39e-04 | 510 | 111 | 8 | 16712791 | ||
| Pubmed | 2.40e-04 | 94 | 111 | 4 | 12761501 | ||
| Pubmed | Stable association between G alpha(q) and phospholipase C beta 1 in living cells. | 2.50e-04 | 95 | 111 | 4 | 16754659 | |
| Pubmed | 2.79e-04 | 8 | 111 | 2 | 23524951 | ||
| Pubmed | 2.79e-04 | 8 | 111 | 2 | 24290141 | ||
| Pubmed | 2.79e-04 | 8 | 111 | 2 | 11528422 | ||
| Pubmed | 2.79e-04 | 8 | 111 | 2 | 15702992 | ||
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 3.04e-04 | 182 | 111 | 5 | 20468064 | |
| Pubmed | 3.17e-04 | 402 | 111 | 7 | 24722188 | ||
| Pubmed | 3.56e-04 | 43 | 111 | 3 | 23597562 | ||
| Pubmed | 3.58e-04 | 9 | 111 | 2 | 25314967 | ||
| Pubmed | A growing family of dual specificity phosphatases with low molecular masses. | 3.58e-04 | 9 | 111 | 2 | 11432789 | |
| Pubmed | 3.58e-04 | 9 | 111 | 2 | 15883645 | ||
| Pubmed | 4.35e-04 | 46 | 111 | 3 | 20301533 | ||
| Pubmed | Eleven densely clustered genes, six of them novel, in 176 kb of mouse t-complex DNA. | 4.47e-04 | 10 | 111 | 2 | 10899141 | |
| Pubmed | 4.93e-04 | 48 | 111 | 3 | 30938680 | ||
| Pubmed | A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. | 5.24e-04 | 205 | 111 | 5 | 12040188 | |
| Pubmed | Methods for Studying Interactions Between Atg8/LC3/GABARAP and LIR-Containing Proteins. | 5.45e-04 | 11 | 111 | 2 | 28253953 | |
| Pubmed | SARM1 and TRAF6 bind to and stabilize PINK1 on depolarized mitochondria. | 5.45e-04 | 11 | 111 | 2 | 23885119 | |
| Pubmed | 5.45e-04 | 11 | 111 | 2 | 17698926 | ||
| Pubmed | 5.89e-04 | 51 | 111 | 3 | 28185240 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | LDAF1 ERGIC2 RB1CC1 EPN2 CLCN7 SLC35F6 GPR89A PRKDC EPN1 MYRF SLC37A4 | 5.95e-04 | 1061 | 111 | 11 | 33845483 |
| Pubmed | 6.52e-04 | 12 | 111 | 2 | 8169823 | ||
| Pubmed | Chromosomal localization of opioid peptide and receptor genes in the mouse. | 6.52e-04 | 12 | 111 | 2 | 7752808 | |
| Pubmed | XIAP and PHB1 Regulate Anoikis through Competitive Binding to TRAF6. | 6.52e-04 | 12 | 111 | 2 | 36346305 | |
| Pubmed | 7.08e-04 | 125 | 111 | 4 | 29467281 | ||
| Pubmed | 7.69e-04 | 13 | 111 | 2 | 22724066 | ||
| Pubmed | 8.43e-04 | 131 | 111 | 4 | 31006538 | ||
| Pubmed | 8.59e-04 | 58 | 111 | 3 | 11140838 | ||
| Pubmed | Pigmentation-related genes and their implication in malignant melanoma susceptibility. | 8.96e-04 | 14 | 111 | 2 | 19320733 | |
| Pubmed | 8.96e-04 | 14 | 111 | 2 | 22768092 | ||
| Pubmed | 8.96e-04 | 14 | 111 | 2 | 31857374 | ||
| Pubmed | Mouse chromosomal location of four Na/H exchanger isoform genes. | 8.96e-04 | 14 | 111 | 2 | 8824815 | |
| Pubmed | Mutations in mice that influence natural killer (NK) cell activity. | 8.96e-04 | 14 | 111 | 2 | 6971254 | |
| Pubmed | Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss. | 9.31e-04 | 233 | 111 | 5 | 32290105 | |
| Pubmed | 1.03e-03 | 15 | 111 | 2 | 31417184 | ||
| Pubmed | Iris phenotypes and pigment dispersion caused by genes influencing pigmentation. | 1.03e-03 | 15 | 111 | 2 | 18715234 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | GPR89B IFT140 CNOT11 TRAF6 MYO7A PSMB1 CHORDC1 EPN2 SLC9C1 CTR9 PLCL2 SLC35F6 | 1.06e-03 | 1321 | 111 | 12 | 27173435 |
| Pubmed | 1.17e-03 | 650 | 111 | 8 | 38777146 | ||
| Pubmed | PPP1R21 PIGN DOCK8 ACLY FYCO1 ERGIC2 PARP4 CLCN7 PRKDC SLC37A4 RHOT1 | 1.30e-03 | 1168 | 111 | 11 | 19946888 | |
| Pubmed | 1.49e-03 | 18 | 111 | 2 | 10567358 | ||
| Pubmed | 1.49e-03 | 18 | 111 | 2 | 18985723 | ||
| Cytoband | 8q11 | 8.48e-05 | 6 | 110 | 2 | 8q11 | |
| GeneFamily | Solute carriers | SLC38A4 SLC35G2 SLC22A24 SLC9C2 SLC5A11 SLC7A8 SLC9C1 SLC9A3 SLC10A5 SLC37A4 SLC9A6 | 1.28e-06 | 395 | 80 | 11 | 752 |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 7.68e-05 | 19 | 80 | 3 | 563 | |
| GeneFamily | Transmembrane BAX inhibitor motif containing | 2.87e-04 | 6 | 80 | 2 | 1215 | |
| GeneFamily | MAP kinase phosphatases | 1.04e-03 | 11 | 80 | 2 | 895 | |
| Coexpression | GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_UP | 1.53e-06 | 199 | 106 | 8 | M7041 | |
| Coexpression | GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_DN | 1.75e-05 | 200 | 106 | 7 | M7822 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.97e-06 | 151 | 109 | 6 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-06 | 177 | 109 | 6 | 9c7c6824b9011363851f084a500d665f025b026e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-06 | 177 | 109 | 6 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-06 | 177 | 109 | 6 | 2bf639e9e801e5144462ffc957f5739e0dfcd500 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.93e-06 | 177 | 109 | 6 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.91e-06 | 200 | 109 | 6 | cded40d5069a6fdbd90ac9a2a0bbef11727b28d5 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 127 | 109 | 5 | 983489a69d3b1f1fe21110a862ac1dba53e9d31c | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|blood / Manually curated celltypes from each tissue | 2.28e-05 | 138 | 109 | 5 | 9f8389a34c400a6b2b9bf6cef3a71499cc945e35 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.63e-05 | 152 | 109 | 5 | 6d02b50e9e9ecf820f84a79e46d153a4840a1cfe | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.11e-05 | 156 | 109 | 5 | 5b2781d38a83b4b0f8a53cf321ce5db3a07d0818 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.11e-05 | 156 | 109 | 5 | e0aef6104be16b12304b8e30358f444c1660e92f | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-05 | 160 | 109 | 5 | b2d8940ea8c068273b7da1589d3d6ae5110d8209 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 160 | 109 | 5 | 398f162e8a75c6cb5c3e4d1832e98d386e1f222b | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-05 | 160 | 109 | 5 | 9caab1bb63c7e66c44783852ee75b16bb40fa594 | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 160 | 109 | 5 | 12aaab0291035f578e2433efd169ae72f393a5a5 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-05 | 160 | 109 | 5 | 229841be7b984a00a301cd5d88c11226a90d8a88 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.63e-05 | 160 | 109 | 5 | 99c9ae2041445539fada842e1af01368669bfca0 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.77e-05 | 161 | 109 | 5 | d72c572613f8eff3251cb7b1e9dcc76d193b2f21 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.91e-05 | 162 | 109 | 5 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.06e-05 | 163 | 109 | 5 | 13f76f2979558f5cd27fbfd1659b413b3cac18f5 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.36e-05 | 165 | 109 | 5 | 004d793bf5bb6fb3b7bf38baf11b32d46375fe4d | |
| ToppCell | facs-Heart-RV-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 166 | 109 | 5 | c0fd3f3f5c3412746da279b856af0d28b9b70c5d | |
| ToppCell | facs-Heart-RV-3m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 166 | 109 | 5 | 33c4876df43b4c1d100699bca47459918bd054d6 | |
| ToppCell | facs-Heart-RV-3m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 166 | 109 | 5 | ac9b9df57d65ccbbf9ae3add50c5663efcd30dcb | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-05 | 169 | 109 | 5 | 7be742160e3e7e6c8f86b037be4e425f4d4cf663 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-05 | 169 | 109 | 5 | 4ccf5cfa4fe72d3af056d658460a9ccaa07b01be | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 171 | 109 | 5 | dca4aa921896ec935fb7acdf25a62d8eba679602 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 171 | 109 | 5 | d9ad6a3bce3556abd24af1630bf4a99594437c3a | |
| ToppCell | facs-Marrow-Granulocytes-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 171 | 109 | 5 | add2f7d34889ec654b8c71b4b1f084736111dc88 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.71e-05 | 173 | 109 | 5 | b002b22f9968b5967d29fe0eab4e796d87b355fa | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.89e-05 | 174 | 109 | 5 | a62531ebf16b32b249168dca11b870f63a8aa81c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.08e-05 | 175 | 109 | 5 | 0992de1c7bffcb6890584357a7a0a8955927da6c | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 176 | 109 | 5 | 71b3309ddadd035a1224fca4fc5946dc4c0283fe | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-05 | 180 | 109 | 5 | 8bf6e8b6b45ce42f8c5f23e7cd1752ec8b3fa2d2 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.52e-05 | 182 | 109 | 5 | 751bd3e3b49de961523e98197688a05c998c121a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.75e-05 | 183 | 109 | 5 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.75e-05 | 183 | 109 | 5 | 274f274cf60daa30d6a4cd603a3af7823bfb8016 | |
| ToppCell | Control-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations) | 9.20e-05 | 185 | 109 | 5 | 02ab64c0166c0646d1d4c6ed110ef0b75a1096d0 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_early|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.02e-04 | 189 | 109 | 5 | a6c62b456982067ad4d224a2efa3919969000693 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 189 | 109 | 5 | 532aaf02b364c5c4f58a2021c7c21d86df3875c9 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 191 | 109 | 5 | b94e66ac71e73f46b0323d424e7b8b906751d584 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 192 | 109 | 5 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-ILC|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 197 | 109 | 5 | 9791923feefbd78810242113ad2a08ce4c2bb4f2 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.24e-04 | 197 | 109 | 5 | 4961f66606f08e399508fd6cabca588e7ab406a8 | |
| ToppCell | proximal-Epithelial-Neuroendocrine|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-04 | 198 | 109 | 5 | 5dea6078488d584513c0bdbf5bba54877310b54a | |
| ToppCell | proximal-Epithelial-Neuroendocrine-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-04 | 198 | 109 | 5 | 00ccf3020667cf2130bc354b441b65c0b1b0e862 | |
| ToppCell | proximal-3-Epithelial-Neuroendocrine|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.27e-04 | 198 | 109 | 5 | a6bc043faf68468d46bac441cf7447c236c7bae4 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-04 | 198 | 109 | 5 | 0d9d401190792fd61434f1b82548253187d805f0 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-04 | 199 | 109 | 5 | 7d69785717073491b5fb81bf24db0175f86cd0b0 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.30e-04 | 199 | 109 | 5 | eb188b0b457136b6ee485d3b3052baa30d9c0002 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 109 | 5 | 7a9c3f51d4a8fda5f1b7e0be6fcf9c1c92fffe99 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal-BMP_responsible_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-04 | 200 | 109 | 5 | cd0d69f973ca3204b500d12031b403a1f4593431 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.33e-04 | 200 | 109 | 5 | 195862a319794e57f0506757ae45ab70200bc5b4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-04 | 200 | 109 | 5 | fe22f7c97f4e37dfa7881d0f1d9245c1237d873b | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 109 | 5 | e0cec0a844b7c1f8edee4c005af27766754e470a | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 109 | 5 | c6c2b39359c65c9444987d02d1c899dff2ad1366 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Mesenchymal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-04 | 200 | 109 | 5 | 16caefcc5bdca82d904462c6fd0ffa80d96fa474 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 109 | 5 | 66fb892bda1d29e67a65717e85f2ec221f520b2a | |
| ToppCell | Lung_Parenchyma-Control|Lung_Parenchyma / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.33e-04 | 200 | 109 | 5 | 2cb0fba2477d885b62850e473b4b637a5af531a9 | |
| Drug | AC1Q3ZOL | GABRB1 GABRB3 GABRR1 CNOT11 CHRNA9 GRINA GRM8 OPRM1 CACNA2D4 CLCN7 CLCA2 | 4.61e-08 | 258 | 109 | 11 | CID000002376 |
| Drug | gabapentin | 1.57e-06 | 169 | 109 | 8 | CID000003446 | |
| Drug | picrotoxin | 2.62e-06 | 181 | 109 | 8 | CID000031304 | |
| Drug | pentylenetetrazol | 3.09e-06 | 130 | 109 | 7 | CID000005917 | |
| Drug | Quazepam | 3.68e-06 | 7 | 109 | 3 | DB01589 | |
| Drug | ketamine | 4.83e-06 | 262 | 109 | 9 | CID000003821 | |
| Drug | Adinazolam | 5.87e-06 | 8 | 109 | 3 | DB00546 | |
| Drug | Fludiazepam | 5.87e-06 | 8 | 109 | 3 | DB01567 | |
| Drug | Clotiazepam | 5.87e-06 | 8 | 109 | 3 | DB01559 | |
| Drug | Cinolazepam | 5.87e-06 | 8 | 109 | 3 | DB01594 | |
| Drug | Prazepam | 5.87e-06 | 8 | 109 | 3 | DB01588 | |
| Drug | Estazolam | 5.87e-06 | 8 | 109 | 3 | DB01215 | |
| Drug | Halazepam | 5.87e-06 | 8 | 109 | 3 | DB00801 | |
| Drug | 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane | 5.87e-06 | 8 | 109 | 3 | ctd:C091518 | |
| Drug | tetradotoxin | GABRB1 GABRB3 GABRR1 GALR1 CHRNA9 GRINA GRM8 OPRM1 CACNA2D4 SCN3A TACR2 | 6.70e-06 | 428 | 109 | 11 | CID000020382 |
| Drug | Diazepam | 8.78e-06 | 9 | 109 | 3 | DB00829 | |
| Drug | Chlordiazepoxide | 1.25e-05 | 10 | 109 | 3 | DB00475 | |
| Drug | Clobazam | 1.25e-05 | 10 | 109 | 3 | DB00349 | |
| Drug | Bromazepam | 1.25e-05 | 10 | 109 | 3 | DB01558 | |
| Drug | Oxazepam | 1.25e-05 | 10 | 109 | 3 | DB00842 | |
| Drug | Midazolam | 1.25e-05 | 10 | 109 | 3 | DB00683 | |
| Drug | Flurazepam | 1.25e-05 | 10 | 109 | 3 | DB00690 | |
| Drug | Clonazepam | 1.25e-05 | 10 | 109 | 3 | DB01068 | |
| Drug | picrotoxinine | 1.51e-05 | 65 | 109 | 5 | CID000004816 | |
| Drug | Alprazolam | 1.71e-05 | 11 | 109 | 3 | DB00404 | |
| Drug | Temazepam | 1.71e-05 | 11 | 109 | 3 | DB00231 | |
| Drug | Nitrazepam | 1.71e-05 | 11 | 109 | 3 | DB01595 | |
| Drug | Lorazepam | 1.71e-05 | 11 | 109 | 3 | DB00186 | |
| Drug | Triazolam | 1.71e-05 | 11 | 109 | 3 | DB00897 | |
| Drug | Clorazepate | 1.71e-05 | 11 | 109 | 3 | DB00628 | |
| Drug | gamma-aminobutyric acid | GABRB1 GABRB3 GABRR1 CHRNA9 SLC38A4 GRINA GRM8 OPRM1 CACNA2D4 CLCN7 CLCA2 | 1.74e-05 | 474 | 109 | 11 | CID000000119 |
| Drug | enflurane | 1.88e-05 | 68 | 109 | 5 | CID000003226 | |
| Drug | riluzole | 2.09e-05 | 174 | 109 | 7 | CID000005070 | |
| Drug | felbamate | 2.17e-05 | 70 | 109 | 5 | CID000003331 | |
| Drug | ibotenic acid | 2.70e-05 | 122 | 109 | 6 | CID000001233 | |
| Drug | acamprosate | 2.84e-05 | 74 | 109 | 5 | CID000071158 | |
| Drug | heptachlor | 3.70e-05 | 129 | 109 | 6 | CID000003589 | |
| Drug | baclofen | 3.79e-05 | 191 | 109 | 7 | CID000002284 | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A | 3.92e-05 | 192 | 109 | 7 | 4268_UP | |
| Drug | sodium | GABRB1 GABRB3 GPR89B GABRR1 CHRNA9 PPRC1 SLC38A4 CHORDC1 SLC5A11 SLC7A8 CACNA2D4 SLC9A3 SCN3A EPN1 SLC9A6 | 4.38e-05 | 944 | 109 | 15 | CID000000923 |
| Drug | Fluocinonide [356-12-7]; Down 200; 8uM; PC3; HT_HG-U133A | 4.47e-05 | 196 | 109 | 7 | 4314_DN | |
| Drug | atropine sulfate | 4.47e-05 | 347 | 109 | 9 | CID000003661 | |
| Drug | Lactobionic acid [96-82-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 4.62e-05 | 197 | 109 | 7 | 6605_UP | |
| Drug | Suramin sodium salt; Down 200; 10uM; PC3; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 7501_DN | |
| Drug | Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.77e-05 | 198 | 109 | 7 | 4062_DN | |
| Drug | neostigmine | 6.20e-05 | 87 | 109 | 5 | CID000004456 | |
| Drug | benzodiazepine | 6.33e-05 | 142 | 109 | 6 | CID000134664 | |
| Drug | dihydroxyaflavinine | 6.91e-05 | 17 | 109 | 3 | CID000156857 | |
| Drug | MK-801 | 9.06e-05 | 296 | 109 | 8 | CID000001207 | |
| Drug | potassium | PDS5B GPR89B GALR1 CHRNA9 SLC38A4 GRINA GRM8 SLC5A11 SLC7A8 CACNA2D4 SLC9A3 CLCN7 CLCA2 SCN3A SLC9A6 | 9.17e-05 | 1008 | 109 | 15 | CID000000813 |
| Drug | pentobarbital | 1.03e-04 | 224 | 109 | 7 | CID000004737 | |
| Drug | triazolam | 1.31e-04 | 54 | 109 | 4 | CID000005556 | |
| Drug | halothane | 1.36e-04 | 314 | 109 | 8 | CID000003562 | |
| Drug | cyclothiazide | 1.38e-04 | 103 | 109 | 5 | CID000002910 | |
| Drug | endrine | 1.58e-04 | 106 | 109 | 5 | CID000003048 | |
| Drug | methohexital | 2.01e-04 | 24 | 109 | 3 | CID000009034 | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 1.05e-05 | 13 | 100 | 3 | C0751197 | |
| Disease | Hepatic Stupor | 1.05e-05 | 13 | 100 | 3 | C0751198 | |
| Disease | Hepatic Encephalopathy | 1.05e-05 | 13 | 100 | 3 | C0019151 | |
| Disease | Hepatic Coma | 1.05e-05 | 13 | 100 | 3 | C0019147 | |
| Disease | response to efavirenz, virologic response measurement | 4.58e-05 | 58 | 100 | 4 | EFO_0006904, EFO_0006906 | |
| Disease | lysophosphatidylcholine 18:0 measurement | 7.26e-05 | 24 | 100 | 3 | EFO_0010359 | |
| Disease | cholesteryl ester 14:0 measurement | 1.04e-04 | 27 | 100 | 3 | EFO_0010340 | |
| Disease | 1-arachidonylglycerol (20:4) measurement | 1.69e-04 | 6 | 100 | 2 | EFO_0800224 | |
| Disease | 1-arachidonoylglycerophosphocholine measurement | 1.69e-04 | 6 | 100 | 2 | EFO_0021076 | |
| Disease | 1-linoleoylglycerophosphoethanolamine measurement | 1.69e-04 | 6 | 100 | 2 | EFO_0021084 | |
| Disease | arachidonoylcholine measurement | 1.69e-04 | 6 | 100 | 2 | EFO_0800478 | |
| Disease | lysophosphatidylcholine 18:3 measurement | 1.69e-04 | 6 | 100 | 2 | EFO_0021454 | |
| Disease | 1-docosapentaenoyl-GPC (22:5n3) measurement | 1.69e-04 | 6 | 100 | 2 | EFO_0800298 | |
| Disease | Schizophrenia | GABRB1 GABRB3 GABRR1 MCHR2 BACE1 RB1CC1 GRM8 OPRM1 ADAMTS12 PLCL2 IL2RA | 2.03e-04 | 883 | 100 | 11 | C0036341 |
| Disease | eicosapentaenoate (EPA; 20:5n3) measurement | 2.36e-04 | 7 | 100 | 2 | EFO_0800616 | |
| Disease | arachidonate 20:4n6 measurement | 2.36e-04 | 7 | 100 | 2 | EFO_0021063 | |
| Disease | 1-palmitoyl-2-docosahexaenoyl-GPC (16:0/22:6) measurement | 2.36e-04 | 7 | 100 | 2 | EFO_0800391 | |
| Disease | level of Phosphatidylcholine (O-18:2_20:4) in blood serum | 2.36e-04 | 7 | 100 | 2 | OBA_2045135 | |
| Disease | 1-eicosapentaenoyl-GPE (20:5) measurement | 2.36e-04 | 7 | 100 | 2 | EFO_0800353 | |
| Disease | triacylglycerol 56:8 measurement | 2.49e-04 | 36 | 100 | 3 | EFO_0010435 | |
| Disease | Unilateral agenesis of kidney | 3.14e-04 | 8 | 100 | 2 | C0266294 | |
| Disease | hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)) measurement | 3.14e-04 | 8 | 100 | 2 | EFO_0800583 | |
| Disease | stearidonate 18:4n3 measurement | 3.14e-04 | 8 | 100 | 2 | EFO_0021075 | |
| Disease | 1-stearoyl-2-docosahexaenoyl-GPC (18:0/22:6) measurement | 3.14e-04 | 8 | 100 | 2 | EFO_0800392 | |
| Disease | level of Phosphatidylethanolamine (O-18:1_18:2) in blood serum | 3.14e-04 | 8 | 100 | 2 | OBA_2045147 | |
| Disease | level of Phosphatidylethanolamine (O-18:2_20:4) in blood serum | 3.14e-04 | 8 | 100 | 2 | OBA_2045151 | |
| Disease | Combined immunodeficiency | 3.67e-04 | 41 | 100 | 3 | C0494261 | |
| Disease | autistic disorder (is_implicated_in) | 3.94e-04 | 42 | 100 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | 1-arachidonoyl-GPE (20:4n6) measurement | 4.03e-04 | 9 | 100 | 2 | EFO_0800248 | |
| Disease | level of Phosphatidylcholine (O-18:1_18:2) in blood serum | 4.03e-04 | 9 | 100 | 2 | OBA_2045129 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:3) in blood serum | 4.03e-04 | 9 | 100 | 2 | OBA_2045130 | |
| Disease | 1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) measurement | 4.03e-04 | 9 | 100 | 2 | EFO_0800271 | |
| Disease | tyrosine measurement | 4.40e-04 | 104 | 100 | 4 | EFO_0005058 | |
| Disease | level of Phosphatidylcholine (O-18:2_16:0) in blood serum | 5.03e-04 | 10 | 100 | 2 | OBA_2045132 | |
| Disease | cholesteryl ester 22:4 measurement | 5.03e-04 | 10 | 100 | 2 | EFO_0021443 | |
| Disease | phosphatidylethanolamine ether measurement | 5.03e-04 | 10 | 100 | 2 | EFO_0010229 | |
| Disease | phosphatidylcholine 32:0 measurement | 6.13e-04 | 11 | 100 | 2 | EFO_0010372 | |
| Disease | level of Phosphatidylcholine (O-16:1_20:4) in blood serum | 6.13e-04 | 11 | 100 | 2 | OBA_2045123 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 6.21e-04 | 49 | 100 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 7.34e-04 | 12 | 100 | 2 | EFO_0800500 | |
| Disease | level of Phosphatidylcholine (O-16:0_20:3) in blood serum | 7.34e-04 | 12 | 100 | 2 | OBA_2045115 | |
| Disease | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement | 7.34e-04 | 12 | 100 | 2 | EFO_0800453 | |
| Disease | cholesteryl ester 20:2 measurement | 7.34e-04 | 12 | 100 | 2 | EFO_0021440 | |
| Disease | level of Phosphatidylinositol (18:1_18:1) in blood serum | 8.66e-04 | 13 | 100 | 2 | OBA_2045159 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 8.66e-04 | 13 | 100 | 2 | OBA_2045174 | |
| Disease | phosphatidylcholine ether measurement | 8.66e-04 | 13 | 100 | 2 | EFO_0010227 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 8.66e-04 | 13 | 100 | 2 | OBA_2045082 | |
| Disease | level of Phosphatidylcholine (18:1_20:2) in blood serum | 1.01e-03 | 14 | 100 | 2 | OBA_2045102 | |
| Disease | lysophosphatidylcholine 22:5 measurement | 1.01e-03 | 14 | 100 | 2 | EFO_0021462 | |
| Disease | diacylglycerol 38:4 measurement | 1.01e-03 | 14 | 100 | 2 | EFO_0020066 | |
| Disease | cis/trans-18:2 fatty acid measurement, trans fatty acid measurement | 1.16e-03 | 15 | 100 | 2 | EFO_0006821, EFO_0006824 | |
| Disease | oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] measurement | 1.16e-03 | 15 | 100 | 2 | EFO_0800508 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 1.16e-03 | 15 | 100 | 2 | OBA_2045131 | |
| Disease | phosphatidate measurement | 1.16e-03 | 15 | 100 | 2 | EFO_0020047 | |
| Disease | diacylglycerol 36:2 measurement | 1.32e-03 | 16 | 100 | 2 | EFO_0010355 | |
| Disease | level of Phosphatidylcholine (18:0_20:3) in blood serum | 1.32e-03 | 16 | 100 | 2 | OBA_2045093 | |
| Disease | basophil count, eosinophil count | 1.40e-03 | 241 | 100 | 5 | EFO_0004842, EFO_0005090 | |
| Disease | level of Phosphatidylinositol (18:0_18:1) in blood serum | 1.68e-03 | 18 | 100 | 2 | OBA_2045155 | |
| Disease | diacylglycerol 36:3 measurement | 1.68e-03 | 18 | 100 | 2 | EFO_0020062 | |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 1.87e-03 | 19 | 100 | 2 | OBA_2045140 | |
| Disease | diacylglycerol 38:5 measurement | 1.87e-03 | 19 | 100 | 2 | EFO_0020067 | |
| Disease | diacylglycerol 38:3 measurement | 1.87e-03 | 19 | 100 | 2 | EFO_0020065 | |
| Disease | Alcoholic Intoxication, Chronic | 2.22e-03 | 268 | 100 | 5 | C0001973 | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 2.29e-03 | 21 | 100 | 2 | OBA_2045104 | |
| Disease | level of Phosphatidylcholine (16:0_20:4) in blood serum | 2.29e-03 | 21 | 100 | 2 | OBA_2045076 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 2.29e-03 | 21 | 100 | 2 | OBA_2045083 | |
| Disease | Lung diseases | 2.39e-03 | 78 | 100 | 3 | C0024115 | |
| Disease | glomerular filtration rate, renal transplant outcome measurement, donor genotype effect measurement | 2.51e-03 | 22 | 100 | 2 | EFO_0005199, EFO_0005208, EFO_0007892 | |
| Disease | level of Phosphatidylinositol (18:0_20:4) in blood serum | 2.75e-03 | 23 | 100 | 2 | OBA_2045158 | |
| Disease | phosphatidylserines measurement | 2.75e-03 | 23 | 100 | 2 | EFO_0020049 | |
| Disease | gamma-linolenic acid measurement | 2.99e-03 | 24 | 100 | 2 | EFO_0007762 | |
| Disease | alpha-linolenic acid measurement | 3.24e-03 | 25 | 100 | 2 | EFO_0007759 | |
| Disease | diacylglycerol 34:2 measurement | 3.24e-03 | 25 | 100 | 2 | EFO_0010353 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DESTLMTIAYVMAAI | 451 | P56817 | |
| MTDRILYIVSNMSSV | 1 | A0A0U1RQF7 | |
| SSALNTVEMMPNSIY | 146 | Q8WWN8 | |
| SVLSTYTVNDLSMMK | 381 | Q8N4J0 | |
| MTMQTSTLDVTPVIY | 1601 | Q8IZF6 | |
| SRSATIAIAYIMKTM | 251 | Q13202 | |
| IFMKYDLSSLMVTVT | 291 | Q96RQ1 | |
| RTTVSNVKMDILSYM | 201 | P22352 | |
| TASTALTIMVMNIHF | 311 | Q9UGM1 | |
| YIMTSAMLSNAAFVT | 556 | Q9ULK2 | |
| NVESYILTIMNMVTG | 266 | P58397 | |
| ILTYIHTMNVMITNT | 256 | Q8N123 | |
| VAMNIIMSKSTTYSL | 1071 | Q9NTI5 | |
| TTLASTLMEQYMKAT | 791 | P20936 | |
| NMYSSILTMTCISVE | 106 | Q86VZ1 | |
| TCISTLLMLVTSDMY | 371 | Q9UHI5 | |
| STYNVSISTRMVMIE | 326 | Q9NRJ5 | |
| TFMVSESLLLASMAY | 106 | P0C7N1 | |
| SPEMMVESLYSSVIN | 756 | Q8TDY2 | |
| QDMVASVMYTAITPL | 276 | Q8NGR6 | |
| DTTMYEMQALASTLL | 191 | Q8NGE5 | |
| SMITAITIMALYSIV | 66 | P35372 | |
| LSVLTASLSYMVGMI | 231 | Q7Z429 | |
| TISSMYQTKAVIIAM | 181 | Q969X1 | |
| LTYNVVAFSEIMSMV | 46 | O95208 | |
| MSSLVSSYLQTQEMV | 201 | Q9BQS8 | |
| TLSLKDMVTYFMNLS | 331 | Q92485 | |
| AIVYIEEMSSMADVT | 2356 | Q5SZK8 | |
| LTVIMMEATSNVTYG | 566 | P51798 | |
| VMMKYLDNLSTSQLS | 786 | Q6ZWH5 | |
| MMIASYVVVSSLISC | 116 | Q96B96 | |
| SSMETILPIMNQYTE | 126 | Q8IXI2 | |
| SQLSLMDMAYISVTV | 96 | Q8NH00 | |
| FISQLSLMDMAYISV | 66 | Q6IEZ7 | |
| VVAEMASYLETMNIT | 456 | Q6PCE3 | |
| AEYTNIIMMNTLTTT | 226 | P03886 | |
| IIMMNTLTTTIFLGT | 231 | P03886 | |
| SIDMVSEVNMDYTLT | 71 | P18505 | |
| SIDMVSEVNMDYTLT | 71 | P28472 | |
| ETTTYMINLAMSDLL | 51 | P43657 | |
| ISVSYTMILQAVMSL | 216 | Q8NGI0 | |
| DKAVAVFYTMITSML | 266 | Q8NGP0 | |
| QSFSLTMSIEMPYVI | 781 | Q9UKK3 | |
| LTTTKRSYEDQLSMM | 731 | Q6ZMI0 | |
| MYIQTTTLTVSMSLS | 811 | O00222 | |
| LIQQYSEALMALTTM | 911 | Q9C091 | |
| ISSSETVYMNVMTRL | 271 | Q06190 | |
| MYASVLLITAMSLDR | 101 | Q15722 | |
| FISQLSLMDMAYISV | 66 | Q8NH02 | |
| SAIMTVMSVDRYFAL | 121 | Q969V1 | |
| TVSMLVSIFTLAAMS | 116 | P47211 | |
| MTVSMYLFRVTVTSD | 311 | O43826 | |
| VLYSLRVTVTAMCNM | 186 | P24046 | |
| MTDSVIYSMLELPTA | 1 | Q96E93 | |
| TILAYSEEDTAMQMT | 1576 | Q8NF50 | |
| AYSMMTTQVLSLSSL | 206 | Q6ZMU1 | |
| MSFLIDSSIMITSQI | 1 | B7ZAQ6 | |
| MSFLIDSSIMITSQI | 1 | P0CG08 | |
| TQLLSMGVFSQVTMY | 921 | Q7Z3S7 | |
| QTSESLTLAEVYLMM | 681 | Q96RY5 | |
| TQATLLYTMADKIIM | 111 | Q6PD62 | |
| SRSVTVTVAYLMQKM | 336 | Q16829 | |
| MAATMETSIFTTEYQ | 226 | P01589 | |
| VLMCYAIMVTASVSN | 91 | Q6ZNC8 | |
| LTYNVVAFSEIMSMI | 46 | Q9Y6I3 | |
| LAATTSMAYAKLMLT | 481 | Q9HB96 | |
| IICMVTMETSNAYVA | 476 | Q9NZU1 | |
| LMGLYVDMNATTVTV | 56 | Q8N9H9 | |
| ISSMTMLEKLSDTYT | 56 | Q92902 | |
| EMDPVTQLYTMTSTL | 191 | Q13740 | |
| VVSADSTIQMLFYME | 226 | Q96RY7 | |
| TTRLIVNLSQTYMAM | 286 | Q6NUT3 | |
| AAISMVVAMAVYTSE | 101 | Q16617 | |
| LGTMQSYMDASLISL | 91 | Q5VV67 | |
| MTTGAIAAMLSTILY | 111 | P20618 | |
| AMFVSIYSMTAIAAD | 116 | P21452 | |
| METLITAMEQLYTLG | 951 | Q14562 | |
| NKSLVSMSATMAEIY | 91 | Q9BXW4 | |
| TMMTQLKSYLLQSTE | 646 | Q8TB24 | |
| TFMISESLLLASMAY | 106 | Q8NH10 | |
| TVLMYILRMANETDS | 251 | Q8WU17 | |
| AMYLSDTTVTMLANL | 171 | P59539 | |
| KSDIYSFSMIMQEIL | 436 | Q8IWB6 | |
| ATYARQMMFSTTLLI | 471 | Q92581 | |
| LMTSVISLITFTSIM | 176 | Q4G0N8 | |
| SMTIMVLLCSYSVGQ | 231 | Q8N4F4 | |
| SMLSFSLTTAMYLVT | 371 | Q96NR3 | |
| TVMAGLTTALSMIVY | 261 | Q8TBE7 | |
| VTTYDMMIQSLKALI | 1001 | Q9UPR0 | |
| RYTMKMLASSAETII | 336 | P48764 | |
| GMLMLSATQVYTILT | 6 | O43567 | |
| MVAALMSSLTSIFNS | 381 | Q8WWX8 | |
| LSSYQISMEMLEDSS | 686 | Q9NY46 | |
| VSITMQNIGAMSSYL | 156 | Q969I6 | |
| TVSNISITGMLVMYL | 366 | Q969I6 | |
| TSTLLALIMMPVNSY | 241 | Q5PT55 | |
| STMETMNYAQIRTIA | 581 | P53396 | |
| ATASIMFMQSLSSVV | 236 | Q9UQC9 | |
| SYVTMTATKIEITMR | 291 | Q9UHD1 | |
| ITEYFSVLVNMDMSL | 391 | Q9UKZ1 | |
| LMGTISSILSMYQAA | 216 | Q96HA9 | |
| TMFYLSKMTEEQTLV | 141 | Q96N76 | |
| LTAKMETQSMYVSEL | 316 | Q9Y4K3 | |
| LLQSHELMQTVYSMA | 501 | Q9Y2I9 | |
| SISHYVIVMSMTIFL | 891 | O95427 | |
| YVALNMTSASSFQML | 106 | Q8N357 | |
| LTVTSSDEMMKSYVA | 871 | P78527 | |
| QVISLLTMGINSYVM | 411 | Q5TAH2 | |
| AIEVMTVASYLQMSE | 436 | Q96DT7 | |
| MTARTLSLMASLVAY | 1 | Q64LD2 | |
| VYNMVMSDVTISCTS | 101 | Q92547 | |
| MMENYSSLVSLGLSI | 36 | A8MQ14 | |
| TYSMTVIISIMSSFA | 491 | O15146 | |
| DDLLTSYISQMLTAM | 2191 | Q13402 | |
| MAFSVVSMSTLYVLS | 776 | Q9Y2G1 |